Common polymorphism in the aldehyde oxidase gene is a marker of non-response to azathioprine therapy in inflammatory bowel disease

被引：0
|
作者：
Smith, M. A. [1 ]
Marinaki, T. [1 ]
Ansari, A. [1 ]
Sanderson, J. [1 ]
机构：
[1] Guys & St Thomas NHS Fdn Trust, Purine Res Lab, London, England
来源：
GUT | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
094
引用
收藏
页码：A36 / A36
页数：1
相关论文
共 50 条
  • [1] GENETIC POLYMORPHISM IN THE MULTIDRUG RESISTANCE-5 GENE IS ASSOCIATED WITH NON-RESPONSE TO AZATHIOPRINE TREATMENT IN INFLAMMATORY BOWEL DISEASE
    Smith, M. A.
    Marinaki, A. M.
    Sanderson, J. D.
    GUT, 2010, 59 : A65 - A66
  • [2] Genetic Polymorphism in the Multi-Drug Resistance-5 Gene is Associated With Non-Response to Azathioprine Treatment in Inflammatory Bowel Disease
    Smith, Melissa A.
    Marinaki, Anthony M.
    Sanderson, Jeremy D.
    GASTROENTEROLOGY, 2010, 138 (05) : S87 - S88
  • [3] A colonic gene expression signature predicts non-response to anti-inflammatory therapies in inflammatory bowel disease
    Sato, T.
    Li, K.
    Hayden, K.
    Tomsho, L.
    Baribaud, F.
    Brodmerkel, C.
    Greenbaum, L. E.
    Friedman, J. R.
    Curran, M.
    Imai, Y.
    Plevy, S.
    Telesco, S. E.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S25 - S25
  • [4] A PHARMACOGENETIC INDEX TO PREDICT NON-RESPONSE TO THIOPURINES IN INFLAMMATORY BOWEL DISEASE
    Sanderson, J. D.
    Smith, M.
    Baburajan, B.
    Ansari, A.
    Lewis, C.
    Marinaki, T.
    Arenas-Hernandez, M.
    GUT, 2009, 58 : A95 - A95
  • [5] Management of Non-response and Loss of Response to Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease
    Marsal, Jan
    Barreiro-de Acosta, Manuel
    Blumenstein, Irina
    Cappello, Maria
    Bazin, Thomas
    Sebastian, Shaji
    FRONTIERS IN MEDICINE, 2022, 9
  • [6] Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease
    Buhl, Sine
    Dorn-Rasmussen, Maria
    Brynskov, Jorn
    Ainsworth, Mark A.
    Bendtzen, Klaus
    Klausen, Pia Helene
    Bolstad, Nils
    Warren, David J.
    Steenholdt, Casper
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2020, 55 (08) : 884 - 890
  • [7] Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
    Kim, Mi Jin
    Choe, Yon Ho
    PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2013, 16 (02) : 65 - 70
  • [8] AZATHIOPRINE THERAPY FOR INFLAMMATORY BOWEL DISEASE - A PRELIMINARY REPORT
    BROWN, CH
    ACHKAR, E
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1970, 54 (04): : 363 - &
  • [9] EARLY CHANGE IN FAECAL CALPROTECTIN PREDICTS PRIMARY NON-RESPONSE TO ANTI-TNFA THERAPY IN INFLAMMATORY BOWEL DISEASE
    Pavlidis, P.
    Gulati, S.
    Dubois, P.
    Chung-Faye, G.
    Tumova, J.
    Medcalf, L.
    Choong, L. M.
    Sherwood, R.
    Bjarnason, I.
    Hayee, B.
    GUT, 2016, 65 : A149 - A149
  • [10] A Case of Inflammatory Bowel Disease and a Rare Lymphoma on Azathioprine Therapy
    Elden, Andrew C.
    Polanco, Nathalie A. Pena
    Vitolo, Melissa
    Hoffman, James E.
    Moshiree, Baharak
    Levy, Cynthia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S828 - S829
12345